SHEILA GUJRATHI
CIK 1575202 · President & CEO · last filed 2026-03-04
SHEILA GUJRATHI is a President & CEO who has filed 33 SEC Form 4 insider transactions across 7 companies since 2013. The most recent filing, for VTYX, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$8.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.30M
7
33
-$8.02M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Director | 0 | $13.99 | $0 | -$3.07M | 11 | 2026-03-04 |
| JANX | Director | 118,889 | $13.56 | $1.61M | $0 | 6 | 2025-06-13 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 2 | 2020-06-17 |
| GOSS | President & CEO | 4,237,742 | $0.16 | $686.1K | $168.0K | 4 | 2020-02-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 3 | 2018-05-14 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 1 | 2015-12-03 |
| Receptos, Inc. (RCPT) Delisted | Chief Medical Officer | 12,500 | — | — | -$5.11M | 6 | 2015-08-27 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | Ventyx Biosciences, Inc. (VTYX) Delisted | Disp (D) | −130,000 | $0 | EDGAR |
| 2025-06-13 | JANX | Grant (A) | +3,750 | $0 | EDGAR |
| 2025-06-06 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-26 | Ventyx Biosciences, Inc. (VTYX) Delisted | Buy (P) | +130,000 | $300.6K | EDGAR |
| 2024-11-07 | JANX | Other (J) | +4,611 | $0 | EDGAR |
| 2024-06-28 | JANX | Grant (A) | +2,500 | $0 | EDGAR |
| 2024-06-07 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-04 | JANX | Other (J) | +2,986 | $0 | EDGAR |
| 2024-01-23 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | JANX | Grant (A) | — | $0 | EDGAR |